1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Herpes Marker Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 HSV-1 1.2.3 HSV-2 1.2.4 HSV-1/ HSV-2 1.3 Market by Application 1.3.1 Global Herpes Marker Testing Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Research 1.3.3 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Herpes Marker Testing Market Perspective (2017-2028) 2.2 Herpes Marker Testing Growth Trends by Region 2.2.1 Herpes Marker Testing Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Herpes Marker Testing Historic Market Size by Region (2017-2022) 2.2.3 Herpes Marker Testing Forecasted Market Size by Region (2023-2028) 2.3 Herpes Marker Testing Market Dynamics 2.3.1 Herpes Marker Testing Industry Trends 2.3.2 Herpes Marker Testing Market Drivers 2.3.3 Herpes Marker Testing Market Challenges 2.3.4 Herpes Marker Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Herpes Marker Testing Players by Revenue 3.1.1 Global Top Herpes Marker Testing Players by Revenue (2017-2022) 3.1.2 Global Herpes Marker Testing Revenue Market Share by Players (2017-2022) 3.2 Global Herpes Marker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Herpes Marker Testing Revenue 3.4 Global Herpes Marker Testing Market Concentration Ratio 3.4.1 Global Herpes Marker Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Herpes Marker Testing Revenue in 2021 3.5 Herpes Marker Testing Key Players Head office and Area Served 3.6 Key Players Herpes Marker Testing Product Solution and Service 3.7 Date of Enter into Herpes Marker Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Herpes Marker Testing Breakdown Data by Type 4.1 Global Herpes Marker Testing Historic Market Size by Type (2017-2022) 4.2 Global Herpes Marker Testing Forecasted Market Size by Type (2023-2028) 5 Herpes Marker Testing Breakdown Data by Application 5.1 Global Herpes Marker Testing Historic Market Size by Application (2017-2022) 5.2 Global Herpes Marker Testing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Herpes Marker Testing Market Size (2017-2028) 6.2 North America Herpes Marker Testing Market Size by Country (2017-2022) 6.3 North America Herpes Marker Testing Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Herpes Marker Testing Market Size (2017-2028) 7.2 Europe Herpes Marker Testing Market Size by Country (2017-2022) 7.3 Europe Herpes Marker Testing Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Herpes Marker Testing Market Size (2017-2028) 8.2 Asia-Pacific Herpes Marker Testing Market Size by Country (2017-2022) 8.3 Asia-Pacific Herpes Marker Testing Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Herpes Marker Testing Market Size (2017-2028) 9.2 Latin America Herpes Marker Testing Market Size by Country (2017-2022) 9.3 Latin America Herpes Marker Testing Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Herpes Marker Testing Market Size (2017-2028) 10.2 Middle East & Africa Herpes Marker Testing Market Size by Country (2017-2022) 10.3 Middle East & Africa Herpes Marker Testing Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Detail 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Herpes Marker Testing Introduction 11.1.4 Abbott Laboratories Revenue in Herpes Marker Testing Business (2017-2022) 11.1.5 Abbott Laboratories Recent Development 11.2 Abcam Plc 11.2.1 Abcam Plc Company Detail 11.2.2 Abcam Plc Business Overview 11.2.3 Abcam Plc Herpes Marker Testing Introduction 11.2.4 Abcam Plc Revenue in Herpes Marker Testing Business (2017-2022) 11.2.5 Abcam Plc Recent Development 11.3 BioMérieux SA 11.3.1 BioMérieux SA Company Detail 11.3.2 BioMérieux SA Business Overview 11.3.3 BioMérieux SA Herpes Marker Testing Introduction 11.3.4 BioMérieux SA Revenue in Herpes Marker Testing Business (2017-2022) 11.3.5 BioMérieux SA Recent Development 11.4 Thermo Fisher Scientific, Inc. 11.4.1 Thermo Fisher Scientific, Inc. Company Detail 11.4.2 Thermo Fisher Scientific, Inc. Business Overview 11.4.3 Thermo Fisher Scientific, Inc. Herpes Marker Testing Introduction 11.4.4 Thermo Fisher Scientific, Inc. Revenue in Herpes Marker Testing Business (2017-2022) 11.4.5 Thermo Fisher Scientific, Inc. Recent Development 11.5 F. Hoffmann-La Roche Ltd. 11.5.1 F. Hoffmann-La Roche Ltd. Company Detail 11.5.2 F. Hoffmann-La Roche Ltd. Business Overview 11.5.3 F. Hoffmann-La Roche Ltd. Herpes Marker Testing Introduction 11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Herpes Marker Testing Business (2017-2022) 11.5.5 F. Hoffmann-La Roche Ltd. Recent Development 11.6 DiaSorin S.p.A. 11.6.1 DiaSorin S.p.A. Company Detail 11.6.2 DiaSorin S.p.A. Business Overview 11.6.3 DiaSorin S.p.A. Herpes Marker Testing Introduction 11.6.4 DiaSorin S.p.A. Revenue in Herpes Marker Testing Business (2017-2022) 11.6.5 DiaSorin S.p.A. Recent Development 11.7 Quidel Corporation 11.7.1 Quidel Corporation Company Detail 11.7.2 Quidel Corporation Business Overview 11.7.3 Quidel Corporation Herpes Marker Testing Introduction 11.7.4 Quidel Corporation Revenue in Herpes Marker Testing Business (2017-2022) 11.7.5 Quidel Corporation Recent Development 11.8 Luminex Corporation 11.8.1 Luminex Corporation Company Detail 11.8.2 Luminex Corporation Business Overview 11.8.3 Luminex Corporation Herpes Marker Testing Introduction 11.8.4 Luminex Corporation Revenue in Herpes Marker Testing Business (2017-2022) 11.8.5 Luminex Corporation Recent Development 11.9 Merck KGaA 11.9.1 Merck KGaA Company Detail 11.9.2 Merck KGaA Business Overview 11.9.3 Merck KGaA Herpes Marker Testing Introduction 11.9.4 Merck KGaA Revenue in Herpes Marker Testing Business (2017-2022) 11.9.5 Merck KGaA Recent Development 11.10 Qiagen N.V. 11.10.1 Qiagen N.V. Company Detail 11.10.2 Qiagen N.V. Business Overview 11.10.3 Qiagen N.V. Herpes Marker Testing Introduction 11.10.4 Qiagen N.V. Revenue in Herpes Marker Testing Business (2017-2022) 11.10.5 Qiagen N.V. Recent Development 11.11 Norgen Biotek Corp. 11.11.1 Norgen Biotek Corp. Company Detail 11.11.2 Norgen Biotek Corp. Business Overview 11.11.3 Norgen Biotek Corp. Herpes Marker Testing Introduction 11.11.4 Norgen Biotek Corp. Revenue in Herpes Marker Testing Business (2017-2022) 11.11.5 Norgen Biotek Corp. Recent Development 11.12 Hologic Inc. 11.12.1 Hologic Inc. Company Detail 11.12.2 Hologic Inc. Business Overview 11.12.3 Hologic Inc. Herpes Marker Testing Introduction 11.12.4 Hologic Inc. Revenue in Herpes Marker Testing Business (2017-2022) 11.12.5 Hologic Inc. Recent Development 11.13 Bio Rad Laboratories Inc. 11.13.1 Bio Rad Laboratories Inc. Company Detail 11.13.2 Bio Rad Laboratories Inc. Business Overview 11.13.3 Bio Rad Laboratories Inc. Herpes Marker Testing Introduction 11.13.4 Bio Rad Laboratories Inc. Revenue in Herpes Marker Testing Business (2017-2022) 11.13.5 Bio Rad Laboratories Inc. Recent Development 11.14 Meridian Bioscience Inc 11.14.1 Meridian Bioscience Inc Company Detail 11.14.2 Meridian Bioscience Inc Business Overview 11.14.3 Meridian Bioscience Inc Herpes Marker Testing Introduction 11.14.4 Meridian Bioscience Inc Revenue in Herpes Marker Testing Business (2017-2022) 11.14.5 Meridian Bioscience Inc Recent Development 11.15 Teco Diagnostics 11.15.1 Teco Diagnostics Company Detail 11.15.2 Teco Diagnostics Business Overview 11.15.3 Teco Diagnostics Herpes Marker Testing Introduction 11.15.4 Teco Diagnostics Revenue in Herpes Marker Testing Business (2017-2022) 11.15.5 Teco Diagnostics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Herpes Marker Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of HSV-1 Table 3. Key Players of HSV-2 Table 4. Key Players of HSV-1/ HSV-2 Table 5. Global Herpes Marker Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Herpes Marker Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Herpes Marker Testing Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Herpes Marker Testing Market Share by Region (2017-2022) Table 9. Global Herpes Marker Testing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Herpes Marker Testing Market Share by Region (2023-2028) Table 11. Herpes Marker Testing Market Trends Table 12. Herpes Marker Testing Market Drivers Table 13. Herpes Marker Testing Market Challenges Table 14. Herpes Marker Testing Market Restraints Table 15. Global Herpes Marker Testing Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Herpes Marker Testing Market Share by Players (2017-2022) Table 17. Global Top Herpes Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Marker Testing as of 2021) Table 18. Ranking of Global Top Herpes Marker Testing Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Herpes Marker Testing Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Herpes Marker Testing Product Solution and Service Table 22. Date of Enter into Herpes Marker Testing Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Herpes Marker Testing Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Herpes Marker Testing Revenue Market Share by Type (2017-2022) Table 26. Global Herpes Marker Testing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Herpes Marker Testing Revenue Market Share by Type (2023-2028) Table 28. Global Herpes Marker Testing Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Herpes Marker Testing Revenue Market Share by Application (2017-2022) Table 30. Global Herpes Marker Testing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Herpes Marker Testing Revenue Market Share by Application (2023-2028) Table 32. North America Herpes Marker Testing Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Herpes Marker Testing Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Herpes Marker Testing Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Herpes Marker Testing Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Herpes Marker Testing Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Herpes Marker Testing Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Herpes Marker Testing Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Herpes Marker Testing Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Herpes Marker Testing Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Herpes Marker Testing Market Size by Country (2023-2028) & (US$ Million) Table 42. Abbott Laboratories Company Detail Table 43. Abbott Laboratories Business Overview Table 44. Abbott Laboratories Herpes Marker Testing Product Table 45. Abbott Laboratories Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 46. Abbott Laboratories Recent Development Table 47. Abcam Plc Company Detail Table 48. Abcam Plc Business Overview Table 49. Abcam Plc Herpes Marker Testing Product Table 50. Abcam Plc Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 51. Abcam Plc Recent Development Table 52. BioMérieux SA Company Detail Table 53. BioMérieux SA Business Overview Table 54. BioMérieux SA Herpes Marker Testing Product Table 55. BioMérieux SA Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 56. BioMérieux SA Recent Development Table 57. Thermo Fisher Scientific, Inc. Company Detail Table 58. Thermo Fisher Scientific, Inc. Business Overview Table 59. Thermo Fisher Scientific, Inc. Herpes Marker Testing Product Table 60. Thermo Fisher Scientific, Inc. Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 61. Thermo Fisher Scientific, Inc. Recent Development Table 62. F. Hoffmann-La Roche Ltd. Company Detail Table 63. F. Hoffmann-La Roche Ltd. Business Overview Table 64. F. Hoffmann-La Roche Ltd. Herpes Marker Testing Product Table 65. F. Hoffmann-La Roche Ltd. Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 66. F. Hoffmann-La Roche Ltd. Recent Development Table 67. DiaSorin S.p.A. Company Detail Table 68. DiaSorin S.p.A. Business Overview Table 69. DiaSorin S.p.A. Herpes Marker Testing Product Table 70. DiaSorin S.p.A. Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 71. DiaSorin S.p.A. Recent Development Table 72. Quidel Corporation Company Detail Table 73. Quidel Corporation Business Overview Table 74. Quidel Corporation Herpes Marker Testing Product Table 75. Quidel Corporation Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 76. Quidel Corporation Recent Development Table 77. Luminex Corporation Company Detail Table 78. Luminex Corporation Business Overview Table 79. Luminex Corporation Herpes Marker Testing Product Table 80. Luminex Corporation Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 81. Luminex Corporation Recent Development Table 82. Merck KGaA Company Detail Table 83. Merck KGaA Business Overview Table 84. Merck KGaA Herpes Marker Testing Product Table 85. Merck KGaA Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 86. Merck KGaA Recent Development Table 87. Qiagen N.V. Company Detail Table 88. Qiagen N.V. Business Overview Table 89. Qiagen N.V. Herpes Marker Testing Product Table 90. Qiagen N.V. Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 91. Qiagen N.V. Recent Development Table 92. Norgen Biotek Corp. Company Detail Table 93. Norgen Biotek Corp. Business Overview Table 94. Norgen Biotek Corp. Herpes Marker TestingProduct Table 95. Norgen Biotek Corp. Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 96. Norgen Biotek Corp. Recent Development Table 97. Hologic Inc. Company Detail Table 98. Hologic Inc. Business Overview Table 99. Hologic Inc. Herpes Marker TestingProduct Table 100. Hologic Inc. Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 101. Hologic Inc. Recent Development Table 102. Bio Rad Laboratories Inc. Company Detail Table 103. Bio Rad Laboratories Inc. Business Overview Table 104. Bio Rad Laboratories Inc. Herpes Marker TestingProduct Table 105. Bio Rad Laboratories Inc. Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 106. Bio Rad Laboratories Inc. Recent Development Table 107. Meridian Bioscience Inc Company Detail Table 108. Meridian Bioscience Inc Business Overview Table 109. Meridian Bioscience Inc Herpes Marker TestingProduct Table 110. Meridian Bioscience Inc Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 111. Meridian Bioscience Inc Recent Development Table 112. Teco Diagnostics Company Detail Table 113. Teco Diagnostics Business Overview Table 114. Teco Diagnostics Herpes Marker TestingProduct Table 115. Teco Diagnostics Revenue in Herpes Marker Testing Business (2017-2022) & (US$ Million) Table 116. Teco Diagnostics Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global Herpes Marker Testing Market Share by Type: 2021 VS 2028 Figure 2. HSV-1 Features Figure 3. HSV-2 Features Figure 4. HSV-1/ HSV-2 Features Figure 5. Global Herpes Marker Testing Market Share by Application in 2021 & 2028 Figure 6. Research Case Studies Figure 7. Clinic Case Studies Figure 8. Herpes Marker Testing Report Years Considered Figure 9. Global Herpes Marker Testing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Herpes Marker Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Herpes Marker Testing Market Share by Region: 2021 VS 2028 Figure 12. Global Herpes Marker Testing Market Share by Players in 2021 Figure 13. Global Top Herpes Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Marker Testing as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Herpes Marker Testing Revenue in 2021 Figure 15. North America Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Herpes Marker Testing Market Share by Country (2017-2028) Figure 17. United States Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Herpes Marker Testing Market Share by Country (2017-2028) Figure 21. Germany Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Herpes Marker Testing Market Share by Region (2017-2028) Figure 29. China Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Herpes Marker Testing Market Share by Country (2017-2028) Figure 37. Mexico Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Herpes Marker Testing Market Share by Country (2017-2028) Figure 41. Turkey Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Herpes Marker Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Abbott Laboratories Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 44. Abcam Plc Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 45. BioMérieux SA Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 46. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 47. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 48. DiaSorin S.p.A. Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 49. Quidel Corporation Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 50. Luminex Corporation Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 51. Merck KGaA Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 52. Qiagen N.V. Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 53. Norgen Biotek Corp. Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 54. Hologic Inc. Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 55. Bio Rad Laboratories Inc. Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 56. Meridian Bioscience Inc Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 57. Teco Diagnostics Revenue Growth Rate in Herpes Marker Testing Business (2017-2022) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Abbott Laboratories Abcam Plc BioMérieux SA Thermo Fisher Scientific, Inc. F. Hoffmann-La Roche Ltd. DiaSorin S.p.A. Quidel Corporation Luminex Corporation Merck KGaA Qiagen N.V. Norgen Biotek Corp. Hologic Inc. Bio Rad Laboratories Inc. Meridian Bioscience Inc Teco Diagnostics